MRCT’s Justin Bryans has contributed to a Nature Reviews Drug Discovery article on crowd sourcing in drug discovery.
To read the article please click here (may require subscription).
LifeArc’s Chief Scientific Officer Dr Dave Powell comments on news that lecanemab has received regulatory and safety approval from the FDA.
We’ve seen some exciting scientific progress, forged new partnerships and launched some new landmark initiatives.
We cautiously welcome the Government's announcement on how their £50m commitment into MND research will be spent.